SAGE: Rega marang dodolan Sage Therapeutics, Inc

Logo korporat perusahaan Sage Therapeutics Inc. (SAGE)

Liquidity risks and dependence on the implementation of new products are evident through the historical P/S level, where the value of 7.80 corresponds to the current metric. Patent protection for niche depression treatments provides stability. Research transparency and the partnership with Biogen guarantee strict management oversight, which minimizes operating expenses and strengthens the position of Sage Therapeutics, Inc. (SAGE) in neuromedicine.

SAGE: Multiplikator P/S Sage Therapeutics, Inc. 04.07.2022 - 16.08.2025

Rincian analitis perusahaan Sage Therapeutics Inc. (SAGE)

Ringkesan analitik perusahaan:SAGE Sage Therapeutics, Inc
Barang unggulan Sage Therapeutics

To objectively measure the operational success of Sage Therapeutics, Inc. (SAGE), investors must correlate market capitalization with actual revenue volume. By analyzing the P/S multiple chart, one can assess the cost of each unit of sales, which is particularly significant for a biopharmaceutical company with a diversified drug portfolio and a developed CNS pipeline that minimizes patent cliff risks over the long term.

Karo sapa Sage Therapeutics, Inc. saingan

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Corp)|Regencell Bioscience - Rasio rega marang pendapatan|Axsome Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Rasio rega marang pendapatan|Rega marang dodolan Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Multiplikator P/S|CPRX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DNLI|Koefisien rega marang pendapatan Harmony Biosciences|Biohaven Ltd - Kapitalisasi marang pendapatan|Multiplikator P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Praxis Corp PRAX|AVXL: Multiplikator P/S|CBLL (ceribell.com) - Rasio rega marang pendapatan|PRTA (Prothena Corporation) - Multiplikator P/S|Kapitalisasi marang pendapatan alector.com (ALEC)|Rasio rega marang pendapatan Annexon, Inc. (ANNX)|OMER - Rega marang dodolan|Multiplikator P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rega marang dodolan|Voyager Therapeutics Inc - Multiplikator P/S|Neumora (NMRA) - Kapitalisasi marang pendapatan|SCLX: Multiplikator P/S|TVGN - Koefisien rega marang pendapatan|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan cogrx.com (CGTX)|Rasio rega marang pendapatan Inhibikase Therapeutics Inc (IKT)|Koefisien rega marang pendapatan Cassava Sciences|Multiplikator P/S ASRT (Assertio Holdings)|COYA - Kapitalisasi marang pendapatan|vistagen.com - Multiplikator P/S|OVID: Rasio rega marang pendapatan|Acumen Pharmaceuticals, Inc (ABOS) - Rasio rega marang pendapatan|CervoMed Inc - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alterity Therapeutics Limited|clene.com (CLNN) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan PEPG (PepGen Inc)|Multiplikator P/S jupiterneurosciences.com (JUNS)|Rasio rega marang pendapatan Relmada Therapeutics, Inc. RLMD|ANVS: Rasio kapitalisasi marang pendapatan|Grace Tx - Multiplikator P/S|AIFF (Firefly Neuroscience Inc) - Rasio kapitalisasi marang pendapatan|KLTO: Multiplikator P/S|NeuroSense Therapeutics, Ltd. (NRSN) - Multiplikator P/S|Rasio rega marang pendapatan Reviva Pharmaceuticals, Inc.|Kapitalisasi marang pendapatan metaviatx.com (MTVA)|Multiplikator P/S NRXS|HSDT - Rega marang dodolan|Passage Bio, Inc. - Kapitalisasi marang pendapatan|bionomics.com.au (NEUP) - Rega marang dodolan|Minerva - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ATHA (Athira Pharma Inc)|ADXN: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator P/S|PTIX (Protagenic Therapeutics) - Kapitalisasi marang volume dodolan|Multiplikator P/S KTTA|Koefisien rega marang pendapatan Cortigent|Multiplikator P/S ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang pendapatan|Cara Therapeutics Inc. - Multiplikator P/S|Chromocell Therapeutics (CHRO) - Kapitalisasi marang pendapatan|ELYM: Multiplikator P/S|Kapitalisasi marang pendapatan Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Multiplikator P/S|Marinus - Rasio rega marang dodolan|Multiplikator P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rasio kapitalisasi pasar marang pendapatan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan